! Oncolin Therapeutics: Advancing Technology to Treat Cancer
 
 
 
About Us Technologies Ivestor Realtions Pipeline Contact
 
 
 
 

Agreement with M.D. Anderson providing the right to negotiate a license for five technologies relating to treatment of cancers.
National Institute of Health
Peer Reviewed National Institute of Health Grant of $179,000 to support research on thermally targeted delivery of Doxorubicin.

 

 
 

Copyright © 2008 Oncolin Therapeutics, Inc - All Rights Reserved
About Us | Technologies | Investor Relations | Pipeline | Contact Us | Privacy